FAQS

Blood tests are not required for everyone. However, if you have diabetes, pre-diabetes, or other relevant health conditions, your prescriber may ask for recent test results before making a clinical decision. This will be discussed during your consultation.

You will need to provide:

• a valid form of photo ID to verify your identity;
• accurate details of your current height, weight, and relevant medical history; and
• details of any current medications, supplements, or health conditions.

For weight management medicines, your prescriber will independently assess your BMI and clinical suitability as part of the consultation. Photo ID is used for identity verification only — clinical eligibility is determined by your prescriber, not by a photograph.

You begin by completing an online health assessment covering your medical history, current medications, and relevant health information. A qualified prescriber at AIOS Technology Ltd — our CQC-registered clinical partner — will then review your information and conduct a two-way clinical consultation to assess whether treatment is appropriate for you.

For weight management medicines, this is not a questionnaire-only process. Your prescriber will engage with you directly and may ask follow-up questions before making any prescribing decision.

If treatment is approved, a prescription will be issued and your medication dispensed and delivered by Bolt Pharmacy. If you are not approved, you will be notified and no charge will be applied.

All clinical consultations and prescribing decisions are made by qualified prescribers operating under AIOS Technology Ltd, which is registered with the Care Quality Commission (CQC). Prescribers are independent of Bolt Pharmacy and are solely responsible for all clinical decisions. Bolt Pharmacy dispenses medicines only against prescriptions issued by these prescribers.

If your prescriber determines that treatment is not appropriate for you, you will be notified and no payment will be taken. You may be advised to speak with your GP for further guidance.

You may indicate a preference during your health assessment, but the prescribing decision — including which medicine and at what dose — rests entirely with your prescriber. Treatment will only be prescribed if it is clinically appropriate for your individual circumstances.

‍

We offer prescription GLP-1 weight management medicines to patients who meet the appropriate clinical criteria. Following completion of your online health assessment, one of our prescribers will determine whether treatment is suitable and, if so, which medicine is clinically appropriate based on your medical history, current health, BMI, and individual clinical needs.

Prescription weight management medicines may be considered for adults with a BMI of 27 kg/m² or above, or a BMI of 25 kg/m² or above if they have a weight-related health condition, such as high blood pressure, type 2 diabetes or high cholesterol. For people from certain ethnic backgrounds at higher risk of weight-related health conditions, lower BMI thresholds may apply. Eligibility is determined by your prescriber based on your full clinical assessment, so meeting the BMI criteria alone does not guarantee approval.

Side effects vary between medicines but commonly include nausea, constipation, diarrhoea, and fatigue, particularly in the early weeks. These often improve as your body adjusts. Your prescriber will discuss the specific side effects relevant to your treatment during the consultation.

If you experience any unexpected or severe symptoms, stop using your medication and contact your GP or call 111 immediately.

Prescription weight management medicines work best when combined with a reduced-calorie diet and increased physical activity. Your prescriber may advise on lifestyle changes as part of your treatment plan.

Duration of treatment depends on your individual response and clinical circumstances. Your prescriber will review your progress and advise accordingly. Weight management medicines are not a permanent substitute for healthy lifestyle changes.

Some GLP-1 weight management medicines can delay stomach emptying, which may affect the absorption of oral contraceptive pills. If you take an oral contraceptive, discuss this during your consultation so your prescriber can provide appropriate advice. Depending on the medicine prescribed, you may be advised to use an additional barrier method of contraception for a period of time, particularly when starting treatment or after dose increases. You should also speak to your GP or sexual health clinician if you have any concerns about your contraception.

Following each prescription supplied through our service, we notify your registered GP that treatment has been prescribed to support continuity of your care. As part of your registration and use of our service, you consent to this information being shared with your GP. Where additional clinical information is required, or further communication is appropriate, we may also contact your GP in accordance with our clinical governance processes and applicable confidentiality requirements.

GLP-1 weight management medicines are started at the lowest available dose and increased gradually over time. This stepwise approach, known as dose escalation or titration, allows your body to adjust to the medicine and helps minimise side effects.

Your prescriber will follow the appropriate dosing schedule for your medication and review your progress at each check-in. Dose increases are usually considered at 4-week intervals, depending on how well you tolerate the treatment, your side effects, and your weight-loss progress.

If you are experiencing side effects or your response to treatment needs review, your prescriber may recommend staying on your current dose for longer or adjusting your treatment plan.

Regular clinical check-ins are built into your treatment plan. Your prescriber will review your progress, assess any side effects, and advise on whether your dose should be maintained, adjusted, or discontinued. Check-ins take place through the secure messaging system in your account.

What you should do depends on which medication you are taking.

Wegovy® (semaglutide)

• If it has been 5 days or fewer since your missed dose, take it as soon as you remember and then continue with your usual once-weekly schedule.
• If more than 5 days have passed, skip the missed dose and take your next dose on your usual scheduled day.
• Do not take two doses to make up for a missed dose.

Mounjaro® (tirzepatide)

• If it has been 4 days or fewer since your missed dose, take it as soon as possible and then continue with your usual once-weekly schedule.
• If more than 4 days have passed, skip the missed dose and take your next dose on your usual scheduled day.
• Do not take two doses to make up for a missed dose. There should be at least 3 days (72 hours) between doses.

If you are unsure what to do, contact our clinical team through the secure messaging system in your account before taking your next dose.

Yes. You may stop treatment at any time. However, we recommend discussing this with your prescriber first, as they can advise on how to stop safely and what to expect. Do not stop abruptly without speaking to a clinician if you have any underlying health conditions.

Yes. Tracked delivery to your home address within the United Kingdom is included in the cost of your prescription.

Our support team is available by email at team@boltpharmacy.co.uk or by phone on 03330162337 during business hours. For clinical questions — including questions about your treatment, side effects, or dosing — please use the secure messaging system in your account.

No. We supply prescription medicines to eligible patients within the United Kingdom only.

Once your prescription has been issued and your order confirmed, your medication will typically be dispatched within one to two working days. You will receive a tracking notification by email or via your account.

You can request a reorder through your account. Your prescriber will review your request before a new prescription is issued. Do not reorder without completing the required check-in, as your prescriber must confirm it is clinically safe to continue treatment.

All personal and medical data is handled in accordance with the UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018. Medical records are stored securely and accessed only by authorised healthcare professionals involved in your care.

Bolt Healthcare Ltd is registered with the Information Commissioner’s Office (ICO) under registration number ZB678271.

Medical records are retained in accordance with UK legal requirements and NHS records management guidelines — generally a minimum of eight years from the date of your last treatment. You can request further information at team@boltpharmacy.co.uk.

Yes. Under the UK GDPR you have the right to request a copy of the personal data we hold about you. Contact us at team@boltpharmacy.co.uk to make a subject access request. We will respond within one month.

You have the right to request erasure of your personal data in certain circumstances. Healthcare records are subject to minimum retention periods under UK law and may not always be deleted on request. Contact us at team@boltpharmacy.co.uk and we will advise on what applies to your data.

If you are unhappy with any aspect of our service, please contact us in the first instance:

• Email: team@boltpharmacy.co.uk
• Phone: 03330162337
• Post: Bolt Pharmacy, Unit 3C, Frontier Park, Blackburn, Lancashire, BB1 3AL

We aim to acknowledge all complaints within two working days and provide a full response within 20 working days. Full details of our complaints procedure are available on our Complaints page.

If you remain dissatisfied after raising a complaint with us, you may escalate to:

• General Pharmaceutical Council (GPhC): www.pharmacyregulation.org — for concerns about the pharmacy or a pharmacist
• Care Quality Commission (CQC): www.cqc.org.uk — for concerns about the prescribing service
• Information Commissioner’s Office (ICO): www.ico.org.uk — for concerns about how your data has been handled